Managing Quality & Risk:
Virtual Compounding Quality Discussion
October 29, 2025 | 12-1:30pm (eastern)
Discussion for Compounding Outsourcing Facilities and
Related Supply Chain Partners
FDA's Quality Discussion Series is tailored for outsourcing facilities interested in advancing quality and focuses on topics related to quality culture and best practices. The aim of these discussions is to build a robust community of outsourcing facilities with a strong commitment to quality and current good manufacturing practice requirements and to share quality practices across the industry that positively impact patient safety. The Foundation collaborated with the FDA Compounding Quality Center of Excellence to convene a virtual discussion on managing quality and risk.
Speakers included:
- Susan (Sue) Schniepp, Pharmaceuticals Quality Assurance Expert
- David Short, Chief Quality Officer, QuVa Pharma
Learn more about the FDA Compounding Quality Center of Excellence and the Quality Discussion Series.